MYC and cancer: The intricate networks of metabolic control, such as IDH1‐AS1 overexpression inhibiting cell proliferation, are demonstrated by the cMyc–(IDH1‐AS1)–IDH1–αKG/ROS–HIF1α axis that connects two of the most significant cancer metabolism effectors.